Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and NAC for Bipolar Depression
NCT01797575Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Jan 2013
- Primary completion
- Feb 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin, acetylcysteine in bipolar disorder (BD), sponsored by UTHealth Houston. Started Jan 2013; status: completed.
02
Drugs
aspirinacetylcysteine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01797575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01797575.